MedSource expands footprint, adds new service line

Monday, September 18, 2017

Houston-based CRO MedSource is growing its service-offering to include the early stages of clinical development and pipeline planning through Investigational New Drug (IND) submissions. The service, rarely offered by CROs, will be provided by a new department—Scientific Development—which will be responsible for delivering a suite of clinical development services to biotech and pharmaceutical companies wishing to organize their pipeline strategy, prioritize indications, and develop strategies that will efficiently advance new drug candidates into the clinic. The enhanced offering establishes MedSource as a partner that can offer its expertise throughout the entire drug development process, in complement to the execution of clinical trials that has been a mainstay for its 20-year history.

[Read More]

MedSource acquires Datatrial data services division

Wednesday, June 14, 2017

Houston-based MedSource expanded its clinical development repertoire, acquiring the data services division of biometrics and technology company Datatrial in early 2017. The deal both strengthens MedSource’s position as a full-service CRO and paves the way for a greater presence within the European market, accelerating MedSource’s growth trajectory as a result.

[Read More]